Free Trial

Sabra Health Care REIT (NASDAQ:SBRA) Updates FY 2025 Earnings Guidance

Sabra Health Care REIT logo with Finance background

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share guidance of 1.430-1.460 for the period, compared to the consensus earnings per share estimate of 1.460. The company issued revenue guidance of -.

Sabra Health Care REIT Trading Up 1.0 %

Sabra Health Care REIT stock traded up $0.18 during trading hours on Friday, reaching $18.06. 656,479 shares of the company's stock were exchanged, compared to its average volume of 2,312,355. The firm's 50 day simple moving average is $17.37 and its 200 day simple moving average is $17.49. Sabra Health Care REIT has a twelve month low of $13.87 and a twelve month high of $20.03. The firm has a market capitalization of $4.30 billion, a PE ratio of 34.08, a PEG ratio of 1.97 and a beta of 0.88. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The business had revenue of $183.54 million for the quarter, compared to analysts' expectations of $180.23 million. During the same quarter in the previous year, the firm earned $0.35 earnings per share. The business's revenue was up 10.1% on a year-over-year basis. Research analysts predict that Sabra Health Care REIT will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Shareholders of record on Friday, May 16th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.64%. The ex-dividend date of this dividend is Friday, May 16th. Sabra Health Care REIT's payout ratio is currently 203.39%.

Wall Street Analysts Forecast Growth

Separately, Truist Financial boosted their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Sabra Health Care REIT has a consensus rating of "Moderate Buy" and an average price target of $19.33.

Check Out Our Latest Stock Analysis on SBRA

About Sabra Health Care REIT

(Get Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Featured Stories

Should You Invest $1,000 in Sabra Health Care REIT Right Now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines